Global Immunoglobulin Market Expected to Advance at 6.77% CAGR by 2028

 

Triton Market Research presents the Global Immunoglobulin Market report sectioned by Type (IgM, IgD, IgG, IgE, IgA), Delivery Mode (Intravenous, Intramuscular, Subcutaneous), Application (Hypogamma Globulienemia, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, Idiopathic Thrombocytopenic Purpura, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy, Primary Immunodeficiency Diseases, Other Applications), End-user (Homecare, Hospital and Clinics), Sales Channel (Specialty Pharmacy, Hospital Pharmacy, Other Sales Channels), and Geography ( Europe, North America, Latin America, Middle East and Africa, Asia-Pacific).

The report further discusses the Market Summary, Industry Outlook, Impact of COVID-19, Key Insights, Porter’s Five Forces Analysis, Market Attractiveness Index, Vendor Scorecard, Key Market Strategies, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology and Scope, Global Market Size, Forecasts & Analysis (2022-2028).

 

Request free sample:

https://www.tritonmarketresearch.com/reports/immunoglobulin-market#request-free-sample

 

The market report by Triton shows that the global immunoglobulin market is expected to grow at a CAGR of 6.77% during the forecast period 2022-2028.

Immunoglobulins refer to antibodies naturally produced by the body to fight infections and diseases. Generated by plasma cells, they are glycoprotein molecules acting as the critical component of the immune system. They recognize and bind to antigens like viruses and bacteria while aiding in their destruction.

The immunoglobulin market saw growth during as well as the post-COVID-19 pandemic. The market is further expected to grow during the forecasted year due to the driving factors like the increase in the geriatric population, the prevalence of immunodeficiency diseases, autoimmune disorders and increasing research and development activities. However, one of the major factors that restrict the market growth is the high cost of immunoglobulin therapy, which is directly associated with the type of delivery method used and the site of care. Another factor is the high risk of side effects due to immunoglobulin use.

Globally, the Asia-Pacific is expected to become the fastest-growing region in the immunoglobulin market. The rapid rise in the prevalence of different diseases, the rise in the aging population, and the research and development across the region are key factors expected to boost the market’s growth during the forecast period. Further, several market players are launching or are expected to launch innovative products, thereby supporting the immunoglobulin market’s growth.

The leading companies excelling in the immunoglobulin market are Biotest AG, Grifols SA, CSL Behring, Octapharma AG, Bio Products Laboratory, Shanghai Raas Blood Products Co Ltd, Sanquin Plasma Products BV, Adma Biologics, Kamada Ltd, Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, Sanquin Plasma Products BV, Shanghai Raas Blood Products Co Ltd, Takeda Pharmaceutical Company Limited, Kedrion Biopharma, LFB Group, and China Biologic Products Inc.

The products in the biotechnology industry are subject to multiple standards, regulations, and approvals from the regulatory authorities that can challenge the new market player. Thus, these factors lower the threat of new entrants to the existing players. Moreover, there is a high threat to the intensity of competitive rivalry due to industry fragmentation.   Additionally, prominent players have strengthened and expanded their customer base and geographical footings through strategic initiatives such as product launches, collaborations, joint ventures, and investments.

 

Contact Us:

sales@tritonmarketresearch.com

Phone: +44 7441 911839